Linden Thomas Advisory Services’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.1K Buy
18,745
+1,138
+6% +$616 ﹤0.01% 478
2025
Q1
$11.5K Buy
17,607
+1,324
+8% +$868 ﹤0.01% 460
2024
Q4
$16.6K Buy
16,283
+2,914
+22% +$2.97K ﹤0.01% 469
2024
Q3
$11.6K Buy
+13,369
New +$11.6K ﹤0.01% 465